Continue Reading
This article is for pass holders.
30-Day Pass$12.00One-time purchase · no auto-renewalBuy 30 DaysSave $24.00
365-Day Pass$120.00
Already a pass holder? Sign in · Continue with Google
In Short
Cerebras's Q2 'beat' hides a margin collapse: GAAP gross margin fell to 14% from 42%, and the stock dropped 17% after hours. The $25B RPO is a mirage—management dodged on customer concentration and margin recovery. Is this growth or a house of cards? Read the full breakdown.
The Lede and the Real Story
Cerebras Systems reported a headline Q2 that looked like a growth investor’s dream: core revenue doubled year-over-year, guidance was raised, and management boasted of a $25 billion backlog. But peel back the press release and the real story is far less flattering. The company’s GAAP gross margin collapsed to 14%, down from 42% in the prior quarter, and the net loss widened to $112 million—a deterioration that management buried under non-GAAP adjustments and forward-looking hype. The stock’s after-hours reaction told the truth: shares fell 16.85%, erasing $44 in value, as investors focused on the margin implosion and the widening gap between the narrative and the numbers.
The core tension is simple: Cerebras is selling a story of ‘unbound demand’ and ‘massive 2027’ growth, but the financials show a company that is spending aggressively to secure data center capacity—over 600 MW contracted—while its core gross margin fell to 33% (non-GAAP), down from 42% in Q1. The company raised its full-year guidance, but that guidance is built on a foundation of RPO (remaining performance obligations) that may not convert to revenue as quickly as promised. The real story is not growth; it’s the sustainability of that growth in the face of margin compression, rising capex, and a customer concentration that would make any prudent investor nervous.
Inside the Full Analysis
- 🔒The Negative Space — What They Didn’t Say
- 🔒Script vs. Reality
- 🔒Evasion Tactics & The Hot Seat
- 🔒Excuses vs. Execution
- 🔒The CAN SLIM Check
- 🔒Conclusion
Discover more from CANSLIM Research
Subscribe to get the latest posts sent to your email.